Filter & sort
The latest funding rounds from the UK tech ecosystem. Updated 4 November 2026.
Announcements
6,263
Total raised
£165B
disclosed amounts
This month
£177M
raised so far
The online marketplace has raised venture debt to expand its Sell Your Car service into international markets.
"With some fabulous results and learnings in the UK, the company has started its testing in Germany. Ultimately our aims are global – just like the rest of the business,"
Deepbridge Capital backed the seed round to support the commercialisation of advanced space propulsion systems.
"We have been delighted with our progress to date and the significant interest in our technologies from major players in our sector. This next stage of development will see the Company expand on these exciting relationships whilst continuing our product development."
Guinness Asset Management backed the Series A round to fund international growth and product development.
"These are very exciting times for our business,"
Andreessen Horowitz led the Series A round for the faith-based wellness app developer.
"When we first came up with the concept for Glorify, we knew we were onto something big, but as we met with investors, it soon became clear that we've managed to capture lightning in a bottle,"
The financing round was led by Talis Capital with participation from multiple angels and existing backers.
"We are delighted to have received such credible investor support to continue on our mission to empower and support those with cancer. It’s imperative that we start understanding how therapies are affecting patients: for pharmaceutical companies, our technology enables deeper patient understanding which leads to better drugs, greater differentiation and faster licensing, as well as the ability to provide personalised scalable support to patients. For patients, this means better care and improved outcomes from cancer. We’re now looking forward to applying our rich data and machine learning capabilities to novel predictive analytics to generate even richer insights for our life science partners."
